Center for Health Market Innovations (CHMI)

Programs

Sproxil

last updated Jan 26, 2012

Overview

Legal Status: 
Stage: 
Existing/expansion stage
Income Level of Target Population: 
All income levels

Funding

Primary Source of Funding: 
Revenue (e.g., interest on loans)
Funders: 

Technology

Technology Used: 
Phones › SMS/MMS (Text Message)
Technology Purpose: 
Facilitating Patient Communications › General Health Education, Mitigating Fraud & Abuse
Summary: 

Sproxil, Inc., a privately backed organization, provides brand protection for emerging markets through software and services that work anywhere there are mobile phones. Sproxil allows consumers to check the authenticity of drugs they purchase by sending a unique code on the drug as a free text message to the manufacturers, and receive verification in real time.

Key program components: 

Simple, easy to use and with no consumer capital investment, Sproxil offers a comprehensive anti-counterfeiting strategy for cash-based societies. Delivering automatic protection, simple labels and robust back-end analytics with its Mobile Product AuthenticationTM (MPA) solution, Sproxil enables consumers to text message an item-unique code for a rapid response that confirms a brand's genuineness. The system also helps companies connect directly to their consumers through customized text message responses - such as health management tips - and ads that specifically target those demographics with known buying behaviors.

Sproxil acknowledges the fact that consumers are everywhere, and they are a vigilant force that could be leveraged effectively (with the right tools) in the fight against counterfeits. With the explosive growth in mobile phone access in the developing world, it makes a lot of sense to use a participatory, "grass roots" technology that is prevalent in such resource-challenged environments. Sproxil technology is used for many different kinds of products, but it started with pharmaceutical products, helping protect consumers from buying and using counterfeit drugs.

With a $1.8 million investment from the Acumen Fund, Sproxil is now expending its operation to India and parts of East Africa.

By the end of January, 2012, Sproxil had been used to verify medications in Africa over 1 million times.

Need help?

Using the CHMI Programs Database

  • Browse: Browse the database by applying one or more filters to narrow your search by characteristics. Click the "x" to remove any of the filters you've selected. Click "reset search" to remove all filters and start over.
  • Search: Search the database for a specific program by typing a name or keyword into the search box.
  • Add: If the program you're looking for is not in the CHMI database, submit the program to the CHMI pipeline by clicking here to add a program profile.
  • Update: If you notice incorrect or outdated information, or would like to help complete a profile for a CHMI pipeline program, request a change by clicking here, or at the top of the program profile.

Have a question? Check the FAQs first. Don’t see your question? Contact us.